Trials / Sponsors / Alpha Biopharma (Jiangsu) Co., Ltd.
Alpha Biopharma (Jiangsu) Co., Ltd.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Zorifertinib With Osimertinib for NSCLC With Meningeal Progression Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment | Phase 1 | 2026-01-31 |
| Recruiting | A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor EGFR Mutant Advanced Non-small Cell Lung Cancer, Central Nervous System (CNS) Metastases | — | 2025-12-29 |
| Completed | First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) Metas Non-small Cell Lung Cancer, EGFR Gene Mutation, Brain Metastases | Phase 2 / Phase 3 | 2018-10-29 |